• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinical epidemiology survey of the traditional Chinese medicine etiology and syndrome differentiation of coronary artery disease: study protocol of a multicenter trial.

作者信息

Bi Ying-fei, Mao Jing-yuan, Wang Xian-liang, Hou Ya-zhu, Lu Yi-zhu, Soh Shan Bin, Zhang Bo-li

机构信息

Department of Cardiovascular Diseases, the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.

出版信息

Zhong Xi Yi Jie He Xue Bao. 2012 Jun;10(6):619-27. doi: 10.3736/jcim20120604.

DOI:10.3736/jcim20120604
PMID:22704409
Abstract

BACKGROUND

Coronary artery disease (CAD), a common disease with high incidence and mortality rate, has seriously threatened the health and life of the public. Traditional Chinese medicine (TCM) has an important role in the prevention and treatment of this disease. Through clinical epidemiological survey, a deeper understanding of TCM etiology and syndrome characteristics in CAD would further improve clinical efficacy in the treatment of this disease.

METHODS/DESIGN: The preliminary clinical questionnaire for TCM etiology and syndrome differentiation in CAD was designed after literature reviews and analysis. Through a series of clinical pre-surveys, expert consultation and demonstration, the formal TCM clinical epidemiology questionnaire on the etiology and syndrome differentiation in CAD was finalized, after which, the study protocol, inclusive and exclusive criteria and related quality control measures were prepared. The multiregional clinical epidemiological survey with more than 5000 participants with CAD will be carried out in 41 TCM hospitals of China for investigating the TCM etiology and syndrome differentiation of CAD.

DISCUSSION

Multiregion large sample size clinical epidemiology survey on TCM etiology and syndrome differentiation in CAD will provide further evidence in preventing CAD and improving the standardization process of syndrome research.

TRIAL REGISTRATION

This study protocol was registered at the Chinese Clinical Trial Registry on November 27, 2011 in both Chinese and English editions and the registration number is ChiCTR-ECS-11001728.

摘要

相似文献

1
Clinical epidemiology survey of the traditional Chinese medicine etiology and syndrome differentiation of coronary artery disease: study protocol of a multicenter trial.
Zhong Xi Yi Jie He Xue Bao. 2012 Jun;10(6):619-27. doi: 10.3736/jcim20120604.
2
[Syndrome distribution among patients with chronic hepatitis C and interventions of integrated traditional Chinese and Western medicine: study protocol].[慢性丙型肝炎患者的证候分布及中西医结合干预:研究方案]
Zhong Xi Yi Jie He Xue Bao. 2011 Apr;9(4):365-73. doi: 10.3736/jcim20110404.
3
[Expert survey for Chinese medicine syndrome characteristics of different clinical types of coronary artery disease based on the Delphi method].基于德尔菲法的冠心病不同临床类型中医证候特征专家调查
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014 Oct;34(10):1192-6.
4
[Assessment of external methods of traditional Chinese medicine in patients with chronic ulcer of the lower extremities: study protocol of a multicenter, randomized, parallel-group, prospective trial].[中医外治法治疗下肢慢性溃疡患者的评估:一项多中心、随机、平行组、前瞻性试验的研究方案]
Zhong Xi Yi Jie He Xue Bao. 2012 Feb;10(2):166-75. doi: 10.3736/jcim20120207.
5
Study protocol: Traditional Chinese Medicine (TCM) syndrome differentiation for heart failure patients and its implication for long-term therapeutic outcomes of the Qiliqiangxin capsules.研究方案:心力衰竭患者的中医证候辨证及其对芪苈强心胶囊长期治疗效果的影响
Chin Med. 2021 Oct 16;16(1):103. doi: 10.1186/s13020-021-00515-1.
6
Characteristics and advantages of traditional Chinese medicine in the treatment of acute myocardial infarction.中医药治疗急性心肌梗死的特点和优势。
J Tradit Chin Med. 2011 Dec;31(4):269-72. doi: 10.1016/s0254-6272(12)60002-8.
7
Risk of Developing Coronary Artery Disease in Patients with Type 2 Diabetes Receiving Traditional Chinese Medicine Therapy.接受中医治疗的2型糖尿病患者发生冠状动脉疾病的风险
J Altern Complement Med. 2015 Oct;21(10):604-9. doi: 10.1089/acm.2014.0079. Epub 2015 Aug 6.
8
Study on syndrome differentiation and treatment in the management of chronic stable coronary artery disease to improve quality of life.慢性稳定型冠状动脉疾病辨证论治以改善生活质量的研究
Medicine (Baltimore). 2018 Sep;97(36):e12097. doi: 10.1097/MD.0000000000012097.
9
Efficacy and safety of Ding-Kun-Dan for female infertility patients with predicted poor ovarian response undergoing in vitro fertilization/intracytoplasmic sperm injection: study protocol for a randomized controlled trial.定坤丹用于体外受精/卵胞浆内单精子注射治疗中预测卵巢反应不良的女性不孕症患者的疗效与安全性:一项随机对照试验的研究方案
Trials. 2018 Feb 20;19(1):124. doi: 10.1186/s13063-018-2511-0.
10
Assessment of Complementary Treatment with Yiqi Fumai Lyophilized Injection on Acute Decompensated Ischemic Heart Failure (ACT-ADIHF): Rationale and Design of a Multicenter, Randomized, Controlled Trial.益气复脉冻干注射剂治疗急性失代偿性缺血性心力衰竭的评价(ACT-ADIHF):一项多中心、随机、对照试验的原理和设计。
Cardiovasc Drugs Ther. 2018 Jun;32(3):295-300. doi: 10.1007/s10557-018-6791-0.

引用本文的文献

1
Observational Study of the Association between TCM Zheng and Types of Coronary Artery Stenosis: Protocol of a Multicenter Case Series Study.
Evid Based Complement Alternat Med. 2018 Jun 4;2018:2564914. doi: 10.1155/2018/2564914. eCollection 2018.
2
Efficacy and safety of the Shexiang Baoxin Pill for the treatment of coronary artery disease not amenable to revascularisation: study protocol for a randomised, placebo-controlled, double-blinded trial.麝香保心丸治疗不宜血运重建的冠状动脉疾病的疗效和安全性:一项随机、安慰剂对照、双盲试验的研究方案
BMJ Open. 2018 Feb 14;8(2):e018052. doi: 10.1136/bmjopen-2017-018052.
3
Deregulation of microRNA-193b affects the proliferation of liver cancer via myeloid cell leukemia-1.微小RNA-193b的失调通过髓系细胞白血病-1影响肝癌的增殖。
Oncol Lett. 2018 Mar;15(3):2781-2788. doi: 10.3892/ol.2017.7690. Epub 2017 Dec 27.
4
Intermedin attenuates myocardial infarction through activation of autophagy in a rat model of ischemic heart failure via both cAMP and MAPK/ERK1/2 pathways.在缺血性心力衰竭大鼠模型中,肾上腺髓质素通过cAMP和丝裂原活化蛋白激酶/细胞外信号调节激酶1/2(MAPK/ERK1/2)两条途径激活自噬,从而减轻心肌梗死。
Int J Clin Exp Pathol. 2015 Sep 1;8(9):9836-44. eCollection 2015.